Matt Angle

CEO at Paradromics

Matt Angle is the founder and CEO of Paradromics Inc., a company focused on developing next-generation brain-computer interfaces (BCIs) and neural recording technologies.2 3 Here's a comprehensive overview of his background and work:

Education and Early Career

Matt Angle holds a strong academic background in neuroscience and biology:

Bachelor of Science in Biological Sciences from Carnegie Mellon University (2004-2007), focusing on Molecular and Cellular Biology with a minor in Chemistry3
PhD in Neuroscience from the University of Heidelberg (2008-2012)3
Postdoctoral studies in Materials Science and Engineering at Stanford University (2012-2015)3

During his graduate studies at the Max Planck Institute for Medical Research, Angle worked on his thesis titled "Recording Neuronal Activity Using Solid-Conductor Intracellular Nanoelecrodes".3

Professional Experience

CEO at Paradromics Inc. (November 2015 - Present): Angle has been leading Paradromics since its founding, focusing on developing advanced neural interfaces.2 3
Post-doctoral Researcher at Stanford University (September 2012 - November 2015): He worked on designing and characterizing novel interfaces between nanomaterials and cells, aiming to develop next-generation electrical recording technologies for neuroscience.3

Research and Innovations

Angle's research has significantly contributed to the field of neurotechnology:

He has authored numerous scientific papers on topics such as nanoprobes for cell membrane penetration, intracellular nanoelectrodes, and CMOS-hosted in vivo microelectrodes.1
His work has led to several patents related to neural interfaces, signal processing, and electrode technologies.1

Paradromics and BCI Development

Under Angle's leadership, Paradromics is working on creating a high-bandwidth data interface between brains and computers.5 The company's goals include:

Developing the Connexus® Direct Data Interface (DDI), designed for long-term daily use and capable of collecting neural signals at an industry-leading high data rate.7
Focusing on clinical applications to enable severely motor-impaired individuals to communicate and use computers independently.7
Expanding their platform to support future applications that could benefit millions of people.7

Industry Involvement and Expertise

Angle is recognized as a thought leader in the BCI field:

He participates in industry panels and discussions, such as the North American Neuromodulation Society (NANS) annual meeting.6
Angle provides expert commentary on advancements in BCI technology, including insights on developments from other companies like Neuralink.4

Matt Angle's work at Paradromics represents a significant contribution to the rapidly evolving field of brain-computer interfaces, with potential applications in treating various neurological conditions and enhancing human-computer interaction.